Romeoville, Ill., May 09, 2023 (GLOBE NEWSWIRE) — Nanophase Technologies Announces First Quarter 2023
Financial Releases and Conference Call Details
Nanophase Technologies Corporation (OTCQB: NANX), a leader in minerals-based and scientifically-driven healTh care solutions across beauty and life science categories — with innovations that protect skin from environmental aggressors and aid in medical diagnostics — today announced the Company will disseminate a financial news release for the First Quarter 2023 after market close on Thursday, May, 11th A conference call with investors will be held on Friday, May 12.Th.
First Quarter 2023 Conference call
Nanophase will host its First Quarter Conference Call on Friday, May 12ThThe company will hold a conference call on Wednesday, March 20, 2023 at 10:00 AM CDT (11:00 AM EDT) to provide an update and discuss the financial results. On the call will be Jess Jankowski, the Company’s President & CEO, joined by Kevin Cureton, the Company’s Chief Operating Officer.
Registration of Participants:
Register at the link above to receive your dial-in number and PIN. You can also choose to be dialed out by the system once the conference has started. If you forgot your PIN, you can simply register again.
The procedure for listening to the webcast remains unchanged. After the call, you can use the same link to access the replay. Telco’s replay service is no longer available.
Listen-Only Webcast & Replay:
Please connect at least five minutes prior to the scheduled start time of the conference.
The call may also be accessed through the company’s website, at http://www.nanophase.com/Click on Investor Relations and Investor News or the links within this announcement of a conference call.
Nanophase Technologies Corporation, (OTCQB NANX) www.nanohpase.com, a leader in mineral-based health care solutions, across the beauty, life science, and legacy applications of advanced materials, is a pioneer innovator. Leveraging a platform of integrated, patented, and proprietary technologies, the Company creates products with unique performance, enhancing consumers’ health and well-being. We offer commercially available and high quality engineered products, both as components and in fully-formulated products.
Investor Relations Contact: Phone (630) 771-6736